Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 Adaptive versus scheduled (non-adapted) PTV dosimetric comparison

From: Real world clinical experience using daily intelligence-assisted online adaptive radiotherapy for head and neck cancer

Target

Sessions evaluated

Daily mean difference adapted versus scheduled (CI)

p-value

Change per additional session

p-value

Interaction between session and group (p-value)

Mean PTV70

V95

764

1.2% (0.7–1.6%)

 < 0.001

0.003% (− 0.012% to 0.002%)

0.678

0.982

PTV70 Dmax

764

− 1.4% (0.9–1.7%)

 < 0.001

0.019% (0.005% to 0.033%)

0.009

0.814

Mean PTV59.5

V95

764

7.2% (5.0–9.5%)

 < 0.001

0.2% (− 0.306% to 0.101%)

0.832

0.752

Mean PTV56

V95

662

6.0% (3.0–9.0%)

 < 0.001

0.06% (0.03% to 0.09%)

 < 0.001

0.261

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us